ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -11.1% | 301 | 0.0% | 0.00% | – |
| Q2 2023 | $9 | -25.0% | 301 | -10.1% | 0.00% | – |
| Q1 2023 | $12 | -99.4% | 335 | +781.6% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 38 | -46.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 71 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 71 | -68.9% | 0.00% | – |
| Q3 2021 | $8,000 | – | 228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 418 | $11,742 | 0.00% |
| Versant Capital Management, Inc | 20 | $562 | 0.00% |